5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.

@article{Vink20115yearFA,
  title={5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.},
  author={Maarten A. Vink and Maurits T. Dirksen and Maarten Jan Suttorp and Jan G. P. Tijssen and Jeroen van Etten and Mark S. Patterson and Ton Slagboom and Ferdinand Kiemeneij and Gerrit Jan Laarman},
  journal={JACC. Cardiovascular interventions},
  year={2011},
  volume={4 1},
  pages={24-9}
}
OBJECTIVES The purpose of this study was to evaluate the long-term outcomes of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial. BACKGROUND In primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction (STEMI), the use of drug-eluting stents (DES) is still controversial. Several randomized controlled trials of DES, compared with bare-metal stents (BMS), with short-term follow-up showed a… CONTINUE READING